BridgeBio Pharma, Inc. — Director's Dealing 2026

Jan 13, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BridgeBio Pharma, Inc. (BBIO)
CIK: 0001743881
Period of Report: 2026-01-08

Reporting Person: Kumar Neil (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-01-08	Common Stock	S	11515	$73.6446	Disposed	744171	Indirect
2026-01-08	Common Stock	S	8085	$74.3773	Disposed	736086	Indirect
2026-01-08	Common Stock	S	400	$75.1602	Disposed	735686	Indirect
2026-01-08	Common Stock	S	11565	$73.6542	Disposed	4546882	Indirect
2026-01-08	Common Stock	S	8135	$74.3775	Disposed	4538747	Indirect
2026-01-08	Common Stock	S	300	$75.2033	Disposed	4538447	Indirect
2026-01-09	Common Stock	S	2151	$75.752	Disposed	733535	Indirect
2026-01-09	Common Stock	S	6955	$76.7173	Disposed	726580	Indirect
2026-01-09	Common Stock	S	10519	$77.6086	Disposed	716061	Indirect
2026-01-09	Common Stock	S	375	$78.192	Disposed	715686	Indirect
2026-01-09	Common Stock	S	1401	$75.6088	Disposed	4537046	Indirect
2026-01-09	Common Stock	S	6067	$76.527	Disposed	4530979	Indirect
2026-01-09	Common Stock	S	10677	$77.4577	Disposed	4520302	Indirect
2026-01-09	Common Stock	S	1855	$78.1035	Disposed	4518447	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	228776	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.

F2: Represents the weighted average sale price of the shares sold from $73.05 to $74.03 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

F4: Represents the weighted average sale price of the shares sold from $74.06 to $74.94 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F5: Represents the weighted average sale price of the shares sold from $75.09 to $75.28 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F6: Represents the weighted average sale price of the shares sold from $73.08 to $74.06 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F7: Represents the weighted average sale price of the shares sold from $74.08 to $75.00 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F8: Represents the weighted average sale price of the shares sold from $75.12 to $76.11 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F9: Represents the weighted average sale price of the shares sold from $76.13 to $77.125 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F10: Represents the weighted average sale price of the shares sold from $77.16 to $78.12 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F11: Represents the weighted average sale price of the shares sold from $78.16 to $78.21 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F12: Represents the weighted average sale price of the shares sold from $74.99 to $75.97 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F13: Represents the weighted average sale price of the shares sold from $75.99 to $76.985 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F14: Represents the weighted average sale price of the shares sold from $76.99 to $77.96 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F15: Represents the weighted average sale price of the shares sold from $78.00 to $78.32 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.